Ferring Pharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- Ferring Pharmaceuticals's estimated annual revenue is currently $50.3M per year.
- Ferring Pharmaceuticals's estimated revenue per employee is $201,000
Employee Data
- Ferring Pharmaceuticals has 250 Employees.
Ferring Pharmaceuticals's People
Name | Title | Email/Phone |
---|
Ferring Pharmaceuticals Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5M | 25 | -11% | N/A | N/A |
#2 | $35.8M | 178 | 8% | N/A | N/A |
#3 | $5.4M | 27 | -25% | N/A | N/A |
#4 | $4180M | 14516 | 1% | $550M | N/A |
#5 | $12.5M | 62 | 15% | N/A | N/A |
#6 | $6.7M | 119 | -37% | $199.6M | N/A |
#7 | $9.4M | 47 | 7% | N/A | N/A |
#8 | $10.3M | 51 | 6% | N/A | N/A |
#9 | $106.3M | 529 | 16% | N/A | N/A |
#10 | $15.5M | 77 | 20% | N/A | N/A |
What Is Ferring Pharmaceuticals?
Ferring Pharmaceuticals is a research-driven biopharmaceutical company devoted to identifying, developing and marketing innovative products in the fields of infertility, obstetrics, urology, gastroenterology, endocrinology and osteoarthritis. The company's research activities and products are connected by a common thread focused on the provision of tailored treatments that work on the body's own terms to enable doctors to combat numerous diseases and medical conditions. The company has gained international recognition over the last 20 years for the creation of inventive medications that improve the quality of life of children and adults all around the world.
keywords:N/AN/A
Total Funding
250
Number of Employees
$50.3M
Revenue (est)
N/A
Employee Growth %
N/A
Valuation
N/A
Accelerator
Ferring Pharmaceuticals News
... Blue Point Laboratories, Sun Pharmaceutical Industries Ltd., Bachem, Ferring Pharmaceuticals and Amring Pharmaceuticals Inc.
... Blue Point Laboratories, Sun Pharmaceutical Industries Ltd., Bachem, Ferring Pharmaceuticals and Amring Pharmaceuticals Inc.
Gonadorelin Market Outlook and Forecast from 2022-2028 | Merck, Zoetis, Ferring Pharmaceuticals. By. Newsmantraa. Published. April 19, 2022.
Gonadorelin Market Outlook and Forecast from 2022-2028 | Merck, Zoetis, Ferring Pharmaceuticals. By. Newsmantraa. Published. April 19, 2022.
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $58M | 251 | 8% | N/A |
#2 | $79.1M | 283 | 29% | N/A |
#3 | $79.1M | 283 | 29% | N/A |
#4 | $80.3M | 292 | -1% | N/A |
#5 | $54.7M | 296 | 1% | N/A |